{{Rsnum
|rsid=10912580
|Gene=LOC100506023
|Chromosome=1
|position=173287411
|Orientation=plus
|GMAF=0.2039
|Gene_s=IGHVII-15-1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.1 | 34.5 | 4.4
| HCB | 58.4 | 35.8 | 5.8
| JPT | 68.1 | 27.4 | 4.4
| YRI | 79.6 | 20.4 | 0.0
| ASW | 71.4 | 26.8 | 1.8
| CHB | 58.4 | 35.8 | 5.8
| CHD | 56.9 | 34.9 | 8.3
| GIH | 60.4 | 35.6 | 4.0
| LWK | 90.0 | 9.1 | 0.9
| MEX | 37.9 | 50.0 | 12.1
| MKK | 84.0 | 15.4 | 0.6
| TSI | 64.7 | 29.4 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22422496
|Title=Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis
|OA=1
}}

{{PMID Auto
|PMID=19778912
|Title=Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.
|OA=1
}}

{{PMID Auto
|PMID=22870213
|Title=Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}